| Revenue growth | 16% YoY Q2; 15% H1 |
|---|---|
| Margins | Adj. EBITDA margin 19.7%, up from 19.2% |
| Demand visibility | Volume +9%; non-institutional mix 69% |
Growth
Revenue +16% YoY, volume +9%, ARPP +7%; H1 revenue +15%, Adj. EBITDA +18%. Adj. PAT INR 192 Mn, down 9% YoY.
Outlook
Target 1,000 bed addition by FY30 (~3,680 operational). Capex ~INR 1,500 Mn FY27, ~INR 3,000 Mn FY28-29, ~INR 1,000 Mn FY30.
Risks
Karnataka wage revision provision; North Bangalore start-up losses INR 61 Mn; moderating Gujarat growth from institutional mix rationalisation.
Last quarter's promises, checked
Delivered
- Guided mid-teens growth → 16% Q2 / 15% H1 (= BEAT)
- Guided margin to improve progressively → Adj EBITDA 19.4% Q1 → 19.7% Q2 (= BEAT)
- Guided INR 1,700 Mn rights-issue proceeds to repay debt → repaid; net debt INR 5,751 Mn (= BEAT)
Partly delivered
- Guided 21-22% Adj EBITDA in 2 yrs → 19.7% Q2, not yet due (= PARTIAL)
- Guided North Bangalore losses to fall from Q1 peak → INR 61 Mn Q2; Q1 loss not disclosed (= PARTIAL)
- Guided FY27 maintenance capex ~INR 1,000 Mn → H1 capex INR 1,279 Mn, 85% of FY27 ~1,500 Mn guide (= PARTIAL)
Missed
- Guided payor mix to improve in later quarters from 69% → 69% Q2 (= MISS)
Investor Presentation filed with BSE, NSE: HCG. Summary written with AI assistance from the document.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹610.90
- Market cap
- ₹9,121 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 400.0×Sector 53.4×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Results Update
HCG reported Q2 FY27 revenue of INR 7,318 Mn, up 16% YoY, with adjusted EBITDA up 17%. Results cover the quarter and half-year ended September 30, 2026.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Healthcare Global Enterprises Q2 FY27 Results: Net Profit ₹9.2 Cr, Down 55.6% YoY
Healthcare Global Enterprises Ltd reported revenue from operations of ₹731.8 Cr (+13.1% YoY) and net profit of ₹9.2 Cr (-55.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.2 Cr · -55.6% YoY
Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Healthcare Global Enterprises Board Meeting Date
HealthCare Global Enterprises will hold a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Healthcare Global Enterprises Acquisition Worth ₹0 Cr
Healthcare Global's subsidiary, HCG Kenya, increased its stake in Advanced Molecular Imaging Limited (AMIL) to 50.10% by acquiring additional shares for approximately ₹0.003 Crore.
- Value
- ₹0.00 Cr